Singapore, US researchers studying drug to treat haemorrhagic stroke

Assistant Professor Nicolas Kon from the National Neuroscience Institute and Associate Professor Michael Lucas James from Duke University School of Medicine are the lead researchers in the trials.
Assistant Professor Nicolas Kon from the National Neuroscience Institute and Associate Professor Michael Lucas James from Duke University School of Medicine are the lead researchers in the trials.PHOTO: NATIONAL NEUROSCIENCE INSTITUTE

Non-surgical treatment for people who have suffered a more severe form of haemorrhagic stroke could be on the cards if trials here and in the United States prove successful.

Researchers are testing a protein-based compound that reduces inflammation in the brain after injury. It would complement existing treatment for the affliction, which makes up about one-fifth of all stroke cases here but caused 44 per cent of all stroke-related deaths in 2016.

Please or to continue reading the full article. Learn more about ST PREMIUM.

Enjoy unlimited access to ST's best work

  • Exclusive stories and features on multiple devices
  • In-depth analyses and opinion pieces
  • ePaper and award-winning multimedia content
A version of this article appeared in the print edition of The Straits Times on April 10, 2019, with the headline 'S'pore, US researchers studying drug to treat haemorrhagic stroke'. Print Edition | Subscribe